Beijing Chunlizhengda Medical Instruments Co., Ltd. Annual Results: Standalone & Consolidated Reports

Annual Results

Results Snapshot

Figures in Million

Consolidate Annual Results

Dec'25

Dec'24

Dec'23

Dec'22

Dec'21

Dec'20

Dec'19

Net Sales

1,125.10

867.19

1,323.43

1,387.16

1,326.78

1,043.77

964.08

Other Operating Income

0.00

Total Operating income

1,125.10

867.19

1,323.43

1,387.16

1,326.78

1,043.77

964.08

Raw Material Cost

412.99

316.05

392.56

356.67

315.43

296.29

302.50

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

182.37

188.10

245.22

214.33

0.00

135.85

123.71

Power Cost

0.00

Manufacturing Expenses

0.22

1.11

0.40

0.29

0.31

0.16

0.14

Selling and Distribution Expenses

270.64

304.00

466.75

509.81

465.55

309.61

287.87

Other Expenses

-7.04

-5.92

-8.61

-3.74

12.01

-5.89

-6.20

Total Expenditure (Excl Depreciation)

795.79

750.04

1,018.82

1,043.73

901.43

683.02

652.22

Operating Profit (PBDIT) excl Other Income

329.3

117.10000000000001

304.6

343.40000000000003

425.4

360.79999999999995

311.90000000000003

Other Income

29.45

53.06

42.90

58.56

32.32

10.38

8.68

Operating Profit (PBDIT)

363.29

188.90

366.10

416.08

465.41

387.88

323.33

Interest

0.22

1.11

0.40

0.29

0.31

0.16

0.14

Exceptional Items

9.48

-4.26

10.62

11.04

0.00

-0.03

0.00

Gross Profit (PBDT)

712.11

551.13

930.87

1,030.50

1,011.35

747.49

661.58

Depreciation

45.34

40.85

38.29

35.07

22.33

17.04

13.62

Profit Before Tax

327.21

142.68

338.03

391.75

442.77

370.65

309.56

Tax

31.55

7.52

31.04

33.91

54.26

52.22

41.09

Provisions and contingencies

0.00

Profit After Tax

295.58

135.51

306.99

357.84

388.51

318.42

268.47

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

295.58

135.51

306.99

357.84

388.51

318.42

268.47

Share in Profit of Associates

0.00

Minority Interest

0.09

-0.35

-0.01

0.00

Other related items

0.00

Consolidated Net Profit

295.67

135.16

306.99

357.84

388.51

318.42

268.47

Equity Capital

0.00

Face Value

1.11

1.06

1.1

1.12

0.0

Reserves

3,325.26

3,000.97

3,168.11

3,053.52

3,020.34

1,280.00

902.25

Earnings per share (EPS)

0.77

0.35

0.8

0.93

1.01

0.92

0.78

Diluted Earnings per share

0.77

0.35

0.8

0.93

1.01

0.92

0.78

Operating Profit Margin (Excl OI)

25.64%

10.95%

21.53%

23.24%

30.96%

34.53%

31.22%

Gross Profit Margin

33.11%

21.16%

28.44%

30.77%

35.05%

37.14%

33.52%

PAT Margin

26.27%

15.63%

23.2%

25.8%

29.28%

30.51%

27.85%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Annual Analysis Highlights

Net Sales

YoY Growth in year ended Dec 2025 is 29.74% vs -34.47% in Dec 2024

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 118.71% vs -55.96% in Dec 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 145.80% vs -57.98% in Dec 2024

Interest

YoY Growth in year ended Dec 2025 is -81.82% vs 175.00% in Dec 2024

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Beijing Chunlizhengda Medical Instruments Co., Ltd. With

Select Peers

Figures in Million

Consolidate Annual Results

Change(HKD)

Change(%)

Net Sales

1,125.10

833.66

291.44

34.96%

Other Operating Income

0.00

Total Operating income

1,125.10

833.66

291.44

34.96%

Raw Material Cost

412.99

378.89

34.10

9.00%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

182.37

142.85

39.52

27.67%

Power Cost

0.00

Manufacturing Expenses

0.22

0.41

-0.19

-46.34%

Selling and Distribution Expenses

270.64

261.16

9.48

3.63%

Other Expenses

-7.04

-9.54

2.50

26.21%

Total Expenditure (Excl Depreciation)

795.79

687.89

107.90

15.69%

Operating Profit (PBDIT) excl Other Income

329.30

145.77

183.53

125.90%

Other Income

29.45

105.81

-76.36

-72.17%

Operating Profit (PBDIT)

363.29

378.45

-15.16

-4.01%

Interest

0.22

0.41

-0.19

-46.34%

Exceptional Items

9.48

-1.28

10.76

840.62%

Gross Profit (PBDT)

712.11

454.78

257.33

56.58%

Depreciation

45.34

127.66

-82.32

-64.48%

Profit Before Tax

327.21

249.10

78.11

31.36%

Tax

31.55

40.37

-8.82

-21.85%

Provisions and contingencies

0.00

Profit After Tax

295.58

163.48

132.10

80.80%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

295.58

163.48

132.10

80.80%

Share in Profit of Associates

0.00

Minority Interest

0.09

45.26

-45.17

-99.80%

Other related items

0.00

Consolidated Net Profit

295.67

208.74

86.93

41.65%

Equity Capital

0.00

Face Value

1.11

0.00

Reserves

3,325.26

4,226.41

-901.15

-21.32%

Earnings per share (EPS)

0.77

0.11

0.66

600.00%

Diluted Earnings per share

0.77

0.11

0.66

600.00%

Operating Profit Margin (Excl OI)

25.64%

17.39%

0.00

8.25%

Gross Profit Margin

33.11%

45.19%

0.00

-12.08%

PAT Margin

26.27%

19.61%

0.00

6.66%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Annual - Net Sales

Net Sales 112.51 Million

in Dec 2025

Figures in Million

YoY Growth in year ended Dec 2025 is 29.74% vs -34.47% in Dec 2024

Annual - Consolidate Net Profit

Consolidate Net Profit 29.57 Million

in Dec 2025

Figures in Million

YoY Growth in year ended Dec 2025 is 118.71% vs -55.96% in Dec 2024

Annual - Operating Profit (PBDIT)

Operating Profit (PBDIT) 33.38 Million

in Dec 2025

Figures in Million

YoY Growth in year ended Dec 2025 is 145.80% vs -57.98% in Dec 2024

Annual - Interest

Interest 0.02 Million

in Dec 2025

Figures in Million

YoY Growth in year ended Dec 2025 is -81.82% vs 175.00% in Dec 2024

Annual - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 25.64%

in Dec 2025

Figures in %

YoY Growth in year ended Dec 2025 has improved from Dec 2024